Fisetin triggered hair regrowth on shaved mice by boosting TERT in skin cells. The detail that gets dropped from every summary: it was applied to the skin, not swallowed.
Across four different mouse models of kidney injury, fisetin consistently reduced senescent cell burden and fibrosis. But one study found no improvement in actual kidney function. Here’s what that gap means.
Standard fisetin has notoriously poor bioavailability. Liposomal and phytosomal versions promise better absorption — here’s what the actual pharmacokinetic data says.
Fisetin is poorly water-soluble. Learn why pairing it with dietary fat may improve absorption, what timing research suggests, and who should be cautious.
Fisetin and quercetin are both flavonoids studied as senolytics, but their evidence profiles differ significantly. Here is an honest comparison.
Fisetin is under study as a senolytic compound that may clear senescent cells in the dermis. Here is what the current evidence actually shows.
An honest, evidence-based review of fisetin safety for older adults: the senolytic hypothesis, preclinical findings, drug interactions, and real evidence limits
A plain-language look at AFFIRM-LITE, Mayo Clinic’s pilot trial testing fisetin as a senolytic in older adults with physical dysfunction and frailty.
As we navigate the complexities of aging, the quest for interventions that genuinely promote healthspan continues to intensify. Fisetin, a
Break down fisetin cost per dose, learn what drives pricing, and find out how to evaluate quality without overpaying. Informational only, not medical advice.
Fisetin, a plant flavonoid, has shown osteoclast-inhibiting effects in preclinical models via NF-κB and MKP-1 pathways. Here is what the evidence says.
A clear breakdown of fisetin dosage — from preclinical and early human senolytic research to commercial supplement amounts — and why the gap matters.